(Q43236871)
English
TRIO-012: a multicenter, multinational, randomized, double-blind phase III study of IMC-1121B plus docetaxel versus placebo plus docetaxel in previously untreated patients with HER2-negative, unresectable, locally recurrent or metastatic breast canc
scientific article published in November 2009
Statements
1 reference
TRIO-012: a multicenter, multinational, randomized, double-blind phase III study of IMC-1121B plus docetaxel versus placebo plus docetaxel in previously untreated patients with HER2-negative, unresectable, locally recurrent or metastatic breast canc (English)
1 reference
John Mackey
1 reference
Karen Gelmon
1 reference
Miguel Martin
1 reference
Nicole McCarthy
1 reference
Tamas Pinter
1 reference
Mathieu Rupin
1 reference
Hagop Youssoufian
1 reference
1 November 2009
1 reference
1 reference
9
1 reference
4
1 reference
258-261
1 reference
Identifiers
1 reference
1 reference